Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma

NCT05694416 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

MGMT-Unmethylated Glioblastoma

Interventions

DRUG: Etoposide Plus Cisplatin

Sponsor

Zhongnan Hospital